{"nct_id":"NCT02864381","title":"Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2016-09-01","start_date_type":"ACTUAL","primary_completion_date":"2017-11-08","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}